A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)

✍ Scribed by M Untch; S Kahlert; L Petruzelka; M Martin; V Guillem-Porta; M Gil; P Kellokumpu-Lehtinen; D Aubert; J Gasmi; A Chan

• Book ID: 118622194
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 182 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)90846-4